{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:22:33Z","timestamp":1761718953842,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17lk0201034h0003"],"award-info":[{"award-number":["17lk0201034h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.dmpk.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T11:09:44Z","timestamp":1592651384000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessing cytochrome P450-based drug-drug interactions with hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats"],"prefix":"10.1016","volume":"35","author":[{"given":"Masahiro","family":"Tokuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-0448","authenticated-orcid":false,"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2020.06.005_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jfb8010010","article-title":"Overview of potential clinical applications of hemoglobin vesicles (HbV) as artificial red cells, evidenced by preclinical studies of the academic research consortium","volume":"8","author":"Sakai","year":"2017","journal-title":"J\u00a0Funct Biomater"},{"key":"10.1016\/j.dmpk.2020.06.005_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/bc990173h","article-title":"Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state","volume":"11","author":"Sakai","year":"2000","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.dmpk.2020.06.005_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165557","article-title":"Long-term stored hemoglobin-vesicles, a cellular type of hemoglobin-based oxygen carrier, has resuscitative effects comparable to that for fresh red blood cells in a rat model with massive hemorrhage without post-transfusion lung injury","volume":"11","author":"Tokuno","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dmpk.2020.06.005_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/SHK.0b013e31825ad7cf","article-title":"Effect of the cellular-type artificial oxygen carrier hemoglobin vesicle as a resuscitative fluid for prehospital treatment: experiments in a rat uncontrolled hemorrhagic shock model","volume":"38","author":"Seishi","year":"2012","journal-title":"Shock"},{"key":"10.1016\/j.dmpk.2020.06.005_bib5","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1111\/trf.15427","article-title":"Combination therapy using fibrinogen \u03b3-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits","volume":"59","author":"Hagisawa","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.dmpk.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/SHK.0b013e31817d4066","article-title":"Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days","volume":"31","author":"Sakai","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.dmpk.2020.06.005_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/03602532.2011.558094","article-title":"Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells","volume":"43","author":"Taguchi","year":"2011","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmpk.2020.06.005_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.taap.2010.08.006","article-title":"Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment","volume":"248","author":"Taguchi","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmpk.2020.06.005_bib9","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1248\/bpb.b15-00420","article-title":"Biological responsiveness and metabolic performance of liposome-encapsulated hemoglobin (hemoglobin-vesicles) in apolipoprotein E-deficient mice after massive intravenous injection","volume":"38","author":"Taguchi","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.dmpk.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1124\/dmd.109.027094","article-title":"Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier","volume":"37","author":"Taguchi","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd1851","article-title":"Predicting in\u00a0vivo drug interactions from in\u00a0vitro drug discovery data","volume":"4","author":"Wienkers","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmpk.2020.06.005_bib12","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/j.biomaterials.2003.11.005","article-title":"Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model","volume":"25","author":"Sakai","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.dmpk.2020.06.005_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","article-title":"Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUC 1\/AUC) ratios","volume":"32","author":"Williams","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib14","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/pmic.201500433","article-title":"Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: comparison with MRM\/SRM and HR-MRM\/PRM","volume":"16","author":"Nakamura","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.dmpk.2020.06.005_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/dmd.112.048744","article-title":"Carbon monoxide-bound red blood cells protect red blood cell transfusion-induced hepatic cytochrome P450 impairment in hemorrhagic-shock rats","volume":"41","author":"Ogaki","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1248\/bpb.32.717","article-title":"A\u00a0simplified method to determine five cytochrome P450 probe drugs by HPLC in a single run","volume":"32","author":"Liu","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.dmpk.2020.06.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fitote.2013.10.004","article-title":"Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity","volume":"92","author":"Sun","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.dmpk.2020.06.005_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2133\/dmpk.14.286","article-title":"Moment analysis program available on Microsoft Excel","volume":"14","author":"Tabata","year":"1999","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2020.06.005_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2174\/138920307782411392","article-title":"Functional regulation of hepatic cytochrome P450 enzymes by physicochemical properties of phospholipids in biological membranes","volume":"8","author":"Ahn","year":"2007","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.dmpk.2020.06.005_bib20","doi-asserted-by":"crossref","first-page":"18426","DOI":"10.1074\/jbc.M111.240457","article-title":"Inhibition of human cytochrome P450 3A4 by cholesterol","volume":"286","author":"Shinkyo","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dmpk.2020.06.005_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/dmd.118.085340","article-title":"Induction of cytochrome P450 involved in the accelerated blood clearance phenomenon induced by pegylated liposomes in\u00a0vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/dmd.119.086769","article-title":"Activation of pregnane X receptor-cytochrome P450s axis: a possible reason for the enhanced accelerated blood clearance phenomenon of pegylated liposomes in\u00a0vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib23","first-page":"207","article-title":"Regulation of cytochrome P450 by inflammatory mediators: why and how?","volume":"29","author":"Morgan","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1124\/dmd.117.078691","article-title":"Risk of clinically relevant pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and drug administration between 2013 and 2016","volume":"46","author":"Yu","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.06.005_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1124\/dmd.118.084905","article-title":"Mechanisms and clinical significance of pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and drug administration in 2017 s","volume":"47","author":"Yu","year":"2019","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720303785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720303785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T14:36:56Z","timestamp":1600958216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436720303785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1347436720303785"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.06.005","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing cytochrome P450-based drug-drug interactions with hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}